Staphylococcus aureus lipoproteins in infectious diseases
暂无分享,去创建一个
F. Götz | M. Nguyen | R. Pullerits | Abukar Ali | T. Jin | M. Mohammad
[1] Abukar Ali,et al. Commensal Bacteria Augment Staphylococcus aureus septic Arthritis in a Dose-Dependent Manner , 2022, Frontiers in Cellular and Infection Microbiology.
[2] H. Hayen,et al. Lipoproteins Cause Bone Resorption in a Mouse Model of Staphylococcus aureus Septic Arthritis , 2022, Frontiers in Microbiology.
[3] S. Feng,et al. Staphylococcus aureus lipoproteins play crucial roles in inducing inflammatory responses and bacterial internalization into bovine mammary epithelial cells. , 2021, Microbial pathogenesis.
[4] H. Valadi,et al. Lipoproteins Are Responsible for the Pro-Inflammatory Property of Staphylococcus aureus Extracellular Vesicles , 2021, International journal of molecular sciences.
[5] A. Karlsson,et al. Staphylococcus aureus lipoproteins promote abscess formation in mice, shielding bacteria from immune killing , 2021, Communications biology.
[6] R. Pullerits,et al. Bacteria and Host Interplay in Staphylococcus aureus Septic Arthritis and Sepsis , 2021, Pathogens.
[7] Gordon Y C Cheung,et al. Pathogenicity and virulence of Staphylococcus aureus , 2021, Virulence.
[8] D. Missiakas,et al. The Expression of von Willebrand Factor-Binding Protein Determines Joint-Invading Capacity of Staphylococcus aureus, a Core Mechanism of Septic Arthritis , 2020, mBio.
[9] S. Han,et al. Bacterial Lipoproteins Induce BAFF Production via TLR2/MyD88/JNK Signaling Pathways in Dendritic Cells , 2020, Frontiers in Immunology.
[10] F. Götz,et al. Lipoproteins in Gram-Positive Bacteria: Abundance, Function, Fitness , 2020, Frontiers in Microbiology.
[11] Majd Mohammad,et al. Lipoproteins in Staphylococcus aureus infections , 2020 .
[12] Timothy C. Meredith,et al. Lipoprotein N-Acylation in Staphylococcus aureus Is Catalyzed by a Two-Component Acyl Transferase System , 2020, mBio.
[13] Abukar Ali,et al. Tofacitinib treatment aggravates Staphylococcus aureus septic arthritis, but attenuates sepsis and enterotoxin induced shock in mice , 2020, Scientific Reports.
[14] A. Karlsson,et al. The role of Staphylococcus aureus lipoproteins in hematogenous septic arthritis , 2020, Scientific Reports.
[15] B. Maček,et al. Staphylococcus aureus Lpl protein triggers human host cell invasion via activation of Hsp90 receptor , 2020, Cellular microbiology.
[16] Yifan Rao,et al. β-Lactam Antibiotics Enhance the Pathogenicity of Methicillin-Resistant Staphylococcus aureus via SarA-Controlled Lipoprotein-Like Cluster Expression , 2019, mBio.
[17] A. Karlsson,et al. The YIN and YANG of lipoproteins in developing and preventing infectious arthritis by Staphylococcus aureus , 2019, PLoS pathogens.
[18] Timothy C. Meredith,et al. Copper-Induced Expression of a Transmissible Lipoprotein Intramolecular Transacylase Alters Lipoprotein Acylation and the Toll-Like Receptor 2 Response to Listeria monocytogenes , 2019, Journal of bacteriology.
[19] N. D. de Jong,et al. Immune Evasion by Staphylococcus aureus , 2019, Microbiology spectrum.
[20] Suguru Saito,et al. Staphylococcus aureus Lipoprotein Induces Skin Inflammation, Accompanied with IFN-γ-Producing T Cell Accumulation through Dermal Dendritic Cells , 2018, Pathogens.
[21] F. Götz,et al. Toll-Like Receptor 2 and Lipoprotein-Like Lipoproteins Enhance Staphylococcus aureus Invasion in Epithelial Cells , 2018, Infection and Immunity.
[22] Toshiyuki Shimizu,et al. Mechanisms controlling nucleic acid-sensing Toll-like receptors , 2018, International immunology.
[23] O. Tichá,et al. Lipid moieties on lipoproteins of commensal and non-commensal staphylococci induce differential immune responses , 2017, Nature Communications.
[24] P. Zhu,et al. Pretreatment of Pam3CSK4 attenuates inflammatory responses caused by systemic infection of methicillin-resistant Staphylococcus aureus in mice. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[25] F. Götz,et al. Impact of cell wall peptidoglycan O-acetylation on the pathogenesis of Staphylococcus aureus in septic arthritis. , 2017, International journal of medical microbiology : IJMM.
[26] F. Götz,et al. Aspartate tightens the anchoring of staphylococcal lipoproteins to the cytoplasmic membrane , 2017, MicrobiologyOpen.
[27] H. Valadi,et al. Radiological features of experimental staphylococcal septic arthritis by micro computed tomography scan , 2017, PloS one.
[28] Y. Le Loir,et al. Staphylococcus aureus Lpl Lipoproteins Delay G2/M Phase Transition in HeLa Cells , 2016, Front. Cell. Infect. Microbiol..
[29] R. Pullerits,et al. RAGE Deficiency Impairs Bacterial Clearance in Murine Staphylococcal Sepsis, but Has No Significant Impact on Staphylococcal Septic Arthritis , 2016, PloS one.
[30] F. Götz,et al. Evaluation of Staphylococcus aureus Lipoproteins: Role in Nutritional Acquisition and Pathogenicity , 2016, Front. Microbiol..
[31] F. Götz,et al. Lipoproteins of Gram-Positive Bacteria: Key Players in the Immune Response and Virulence , 2016, Microbiology and Molecular Reviews.
[32] M. Pekna,et al. Deficiency of the Complement Component 3 but Not Factor B Aggravates Staphylococcus aureus Septic Arthritis in Mice , 2016, Infection and Immunity.
[33] E. Huizinga,et al. Structural basis for inhibition of TLR2 by staphylococcal superantigen-like protein 3 (SSL3) , 2015, Proceedings of the National Academy of Sciences.
[34] E. Josefsson,et al. IL-1 Receptor Antagonist Treatment Aggravates Staphylococcal Septic Arthritis and Sepsis in Mice , 2015, PloS one.
[35] K. Ohlsen,et al. The νSaα Specific Lipoprotein Like Cluster (lpl) of S. aureus USA300 Contributes to Immune Stimulation and Invasion in Human Cells , 2015, PLoS pathogens.
[36] Vance G. Fowler,et al. Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management , 2015, Clinical Microbiology Reviews.
[37] B. Finlay,et al. Lipoprotein in the cell wall of Staphylococcus aureus is a major inducer of nitric oxide production in murine macrophages. , 2015, Molecular immunology.
[38] E. Josefsson,et al. CTLA4 Immunoglobulin but Not Anti-Tumor Necrosis Factor Therapy Promotes Staphylococcal Septic Arthritis in Mice. , 2015, The Journal of infectious diseases.
[39] N. Buddelmeijer. The molecular mechanism of bacterial lipoprotein modification--how, when and why? , 2015, FEMS microbiology reviews.
[40] Xiaoyang Wang,et al. Antibiotic‐Killed Staphylococcus aureus Induces Destructive Arthritis in Mice , 2015, Arthritis & rheumatology.
[41] H. Rammensee,et al. Cutaneous innate immune sensing of Toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells. , 2014, Immunity.
[42] I. Autenrieth,et al. NOD2 Stimulation by Staphylococcus aureus-Derived Peptidoglycan Is Boosted by Toll-Like Receptor 2 Costimulation with Lipoproteins in Dendritic Cells , 2014, Infection and Immunity.
[43] Eric P. Skaar,et al. IsdB-dependent hemoglobin binding is required for acquisition of heme by Staphylococcus aureus. , 2014, The Journal of infectious diseases.
[44] C. Wolz,et al. Heterogeneity of Host TLR2 Stimulation by Staphylocoocus aureus Isolates , 2014, PloS one.
[45] A. Chong,et al. Protective Immunity against Recurrent Staphylococcus aureus Skin Infection Requires Antibody and Interleukin-17A , 2014, Infection and Immunity.
[46] Timothy J. Foster,et al. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus , 2013, Nature Reviews Microbiology.
[47] Hong-Hee Kim,et al. Lipoproteins are an important bacterial component responsible for bone destruction through the induction of osteoclast differentiation and activation , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[48] Y. Le Loir,et al. Staphylococcus aureus-Induced G2/M Phase Transition Delay in Host Epithelial Cells Increases Bacterial Infective Efficiency , 2013, PloS one.
[49] Eric P. Skaar,et al. Iron in infection and immunity. , 2013, Cell host & microbe.
[50] Friedrich Götz,et al. What distinguishes highly pathogenic staphylococci from medium- and non-pathogenic? , 2013, Current topics in microbiology and immunology.
[51] H. Nakayama,et al. Lipoproteins in bacteria: structures and biosynthetic pathways , 2012, The FEBS journal.
[52] J. McCormick,et al. Staphylococcal superantigens in colonization and disease , 2012, Front. Cell. Inf. Microbio..
[53] H. Nakayama,et al. Environment-Mediated Accumulation of Diacyl Lipoproteins over Their Triacyl Counterparts in Staphylococcus aureus , 2012, Journal of bacteriology.
[54] Eric P. Skaar,et al. A battle for iron: host sequestration and Staphylococcus aureus acquisition. , 2012, Microbes and infection.
[55] D. Heinrichs,et al. The iron-regulated staphylococcal lipoproteins , 2012, Front. Cell. Inf. Microbio..
[56] L. Miller,et al. Innate and adaptive immune responses against Staphylococcus aureus skin infections , 2012, Seminars in Immunopathology.
[57] Eric P Skaar,et al. Molecular mechanisms of Staphylococcus aureus iron acquisition. , 2011, Annual review of microbiology.
[58] E. Josefsson,et al. The combination of a tumor necrosis factor inhibitor and antibiotic alleviates staphylococcal arthritis and sepsis in mice. , 2011, The Journal of infectious diseases.
[59] A. Edwards,et al. How does Staphylococcus aureus escape the bloodstream? , 2011, Trends in microbiology.
[60] F. Taieb,et al. Cycle Inhibiting Factors (Cifs): Cyclomodulins That Usurp the Ubiquitin-Dependent Degradation Pathway of Host Cells , 2011, Toxins.
[61] K. Kurokawa,et al. The role of phagocytosis in IL-8 production by human monocytes in response to lipoproteins on Staphylococcus aureus. , 2011, Biochemical and biophysical research communications.
[62] R. Titball,et al. Lipoproteins of Bacterial Pathogens , 2010, Infection and Immunity.
[63] S. Kaesler,et al. Staphylococcal Peptidoglycan Co-Localizes with Nod2 and TLR2 and Activates Innate Immune Response via Both Receptors in Primary Murine Keratinocytes , 2010, PloS one.
[64] S. Kaesler,et al. Natural Staphylococcus aureus‐derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[65] S. Kaesler,et al. The Staphylococcus aureus Lipoprotein SitC Colocalizes with Toll-Like Receptor 2 (TLR2) in Murine Keratinocytes and Elicits Intracellular TLR2 Accumulation , 2010, Infection and Immunity.
[66] R. Landmann,et al. Staphylococcal lipoproteins and their role in bacterial survival in mice. , 2010, International journal of medical microbiology : IJMM.
[67] T. Kohler,et al. The wall teichoic acid and lipoteichoic acid polymers of Staphylococcus aureus. , 2010, International journal of medical microbiology : IJMM.
[68] J. Belisle,et al. TLR2 looks at lipoproteins. , 2009, Immunity.
[69] T. Lamkemeyer,et al. Role of the Twin-Arginine Translocation Pathway in Staphylococcus , 2009, Journal of bacteriology.
[70] R. Landmann,et al. Lipoproteins in Staphylococcus aureus Mediate Inflammation by TLR2 and Iron-Dependent Growth In Vivo1 , 2009, The Journal of Immunology.
[71] M. Hashimoto,et al. Characterization of N-terminal Structure of TLR2-activating Lipoprotein in Staphylococcus aureus* , 2009, Journal of Biological Chemistry.
[72] S. Akira,et al. The Triacylated ATP Binding Cluster Transporter Substrate-binding Lipoprotein of Staphylococcus aureus Functions as a Native Ligand for Toll-like Receptor 2* , 2009, Journal of Biological Chemistry.
[73] H. Heine,et al. TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. , 2008, Immunobiology.
[74] O. Schneewind,et al. Genome Sequence of Staphylococcus aureus Strain Newman and Comparative Analysis of Staphylococcal Genomes: Polymorphism and Evolution of Two Major Pathogenicity Islands , 2007, Journal of bacteriology.
[75] S. Akira,et al. Both TLR2 and TLR4 are required for the effective immune response in Staphylococcus aureus-induced experimental murine brain abscess. , 2008, The American journal of pathology.
[76] D. Heinrichs,et al. Heme Coordination by Staphylococcus aureus IsdE* , 2007, Journal of Biological Chemistry.
[77] Eric P. Skaar,et al. Staphylococcus aureus IsdB Is a Hemoglobin Receptor Required for Heme Iron Utilization , 2006, Journal of bacteriology.
[78] D. Missiakas,et al. Host defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteins , 2006, Proceedings of the National Academy of Sciences.
[79] M. Hashimoto,et al. Not Lipoteichoic Acid but Lipoproteins Appear to Be the Dominant Immunobiologically Active Compounds in Staphylococcus aureus1 , 2006, The Journal of Immunology.
[80] E. Pearlman,et al. Staphylococcus aureus-Induced Corneal Inflammation Is Dependent on Toll-Like Receptor 2 and Myeloid Differentiation Factor 88 , 2006, Infection and Immunity.
[81] G. Sensabaugh,et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus , 2006, The Lancet.
[82] M. Hashimoto,et al. Lipoprotein is a predominant Toll-like receptor 2 ligand in Staphylococcus aureus cell wall components. , 2006, International immunology.
[83] Ryan M. O’Connell,et al. MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. , 2006, Immunity.
[84] Alex van Belkum,et al. The role of nasal carriage in Staphylococcus aureus infections. , 2005, The Lancet. Infectious diseases.
[85] D. Philpott,et al. Recognition of Staphylococcus aureus by the Innate Immune System , 2005, Clinical Microbiology Reviews.
[86] J. Dengjel,et al. Staphylococcus aureus Deficient in Lipidation of Prelipoproteins Is Attenuated in Growth and Immune Activation , 2005, Infection and Immunity.
[87] D. Heinrichs,et al. FhuD1, a Ferric Hydroxamate-binding Lipoprotein in Staphylococcus aureus , 2004, Journal of Biological Chemistry.
[88] D. Heinrichs,et al. Involvement of SirABC in Iron-Siderophore Import in Staphylococcus aureus , 2004, Journal of bacteriology.
[89] Eric P. Skaar,et al. Iron-Source Preference of Staphylococcus aureus Infections , 2004, Science.
[90] Katherine O'Riordan,et al. Staphylococcus aureus Capsular Polysaccharides , 2004, Clinical Microbiology Reviews.
[91] S. Mazmanian,et al. An iron-regulated sortase anchors a class of surface protein during Staphylococcus aureus pathogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[92] D. Heinrichs,et al. Identification and Characterization offhuD1 and fhuD2, Two Genes Involved in Iron-Hydroxamate Uptake in Staphylococcus aureus , 2001, Journal of bacteriology.
[93] M. Kanehisa,et al. Whole genome sequencing of meticillin-resistant Staphylococcus aureus , 2001, The Lancet.
[94] S. Akira,et al. Cutting Edge: TLR2-Deficient and MyD88-Deficient Mice Are Highly Susceptible to Staphylococcus aureus Infection1 , 2000, The Journal of Immunology.
[95] Philip J. Hill,et al. Molecular Cloning and Analysis of a Putative Siderophore ABC Transporter from Staphylococcus aureus , 2000, Infection and Immunity.
[96] D. Heinrichs,et al. Identification and Characterization of a Membrane Permease Involved in Iron-Hydroxamate Transport inStaphylococcus aureus , 2000, Journal of bacteriology.
[97] D. Heinrichs,et al. Identification and Characterization of a Membrane Permease Involved in Iron-Hydroxamate Transport in Staphylococcus aureus , 2000 .
[98] P. Godowski,et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. , 1999, Science.
[99] B. Bloom,et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. , 1999, Science.
[100] Andrej Tarkowski,et al. Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis , 1999, Nature Medicine.
[101] M. Hanson,et al. Identification and Characterization of SirA, an Iron-Regulated Protein from Staphylococcus aureus , 1999, Journal of bacteriology.
[102] F. Lowy. Staphylococcus aureus infections. , 2009, The New England journal of medicine.
[103] D. Goldenberg,et al. Septic arthritis , 1998, The Lancet.
[104] W. Bessler,et al. A comparative analysis of cytokine production and tolerance induction by bacterial lipopeptides, lipopolysaccharides and Staphyloccocus aureus in human monocytes , 1997, Immunology.
[105] W. Bessler,et al. Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues. , 1988, Immunobiology.
[106] K. Pavelić,et al. Stimulation of humoral immunity by peptidoglycan monomer from Brevibacterium divaricatum. , 1979, Zeitschrift für Immunitätsforschung Immunobiology.
[107] R. Krause. Immunological activity of the peptidoglycan. , 1975, Zeitschrift fur Immunitatsforschung, experimentelle und klinische Immunologie.
[108] V. Braun,et al. Chemical characterization, spatial distribution and function of a lipoprotein (murein-lipoprotein) of the E. coli cell wall. The specific effect of trypsin on the membrane structure. , 1969, European journal of biochemistry.
[109] H. Morton,et al. Staphylococcus aureus , 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.